Google
Trusted Resources: News & Events
Latest announcements and gatherings
The Brain + Executive Function in Sickle Cell Disease: Part 1- A Neuropsychology Perspective
November 21, 2020
11 AM – 1:30 PM PST
Through 3 separate talks, this seminar series will focus on the medical (neurological/developmental), neuropsychological, behavioral, and educational aspects of the neurocognitive complications of sickle cell disease to raise awareness in patients and providers about these challenges.
Our goal is to help raise awareness about the neurocognitive challenges associated with sickle cell disease so that patients, parents, and their families will be able to recognize these issues earlier in life, actively discuss their concerns with their providers in an informed manner, and advocate for necessary treatments and services.
You will learn:
- The role of executive function in child and adult development
- Why and how sickle cell disease can impact executive function
- Diagnostic and treatment options available for executive dysfunction
- Cognitive challenges associated with sickle cell disease, such as ADHD, learning disabilities, and language disorders
We look forward to having you join us during these mini-seminars. Mark your calendars for the others taking place in 2021:
- Saturday, March 20, 2021 from 11 am – 1:30 pm PST
- Saturday, May 22, 2021 from 11 am – 1 pm PST
This event has ended.
+myBinderRelated Content
-
Adverse effect of hydroxyurea on spermatogenesis in patients with sickle cell anemia after 6 months of treatmentThe prognosis of sickle cell anemia (SCA...
-
Mixing Music and Medicine: Meet Grammy-Nominated Producer Nana KwabenaGrammy-nominated songwriter and music pr...
-
Regina Denise Crawford, MDRegina Denise Crawford is an Assistant P...
-
8 Tips to Support Students With Sickle Cell DiseaseIn the United States, sickle cell diseas...
-
Elyse Mandell, MSN, RNCSElyse Mandell is the Nurse Director and ...
-
NIH Launches new Collaboration to Develop Gene-Based Cures for Sickle Cell Disease and HIV on Global ScaleThe National Institutes of Health plans ...
-
SCA Therapy Hydroxyurea Doesn’t Boost Malaria Risk in Sub-Saharan Africa, Study FindsHydroxyurea, a treatment recommended for...
To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences. More Information
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.
Powered by
Support for this site is provided by
This platform is made possible through a partnership with the Sickle Cell Disease Association of America, Inc. (SCDAA) and its member organizations. SCDAA's mission is to advocate for people affected by sickle cell conditions and empower community-based organizations to maximize quality of life and raise public consciousness while advancing the search for a universal cure.